# FDA Inspection 1122166 - Evonik Operations GmbH - February 18, 2020

Source: https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/4b6ac185-e85c-421f-b8ae-aa7f82226b0c
Source feed: FDA_Inspections

> FDA Inspection 1122166 for Evonik Operations GmbH on February 18, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122166
- Company Name: Evonik Operations GmbH
- Inspection Date: 2020-02-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1289284 - 2024-06-27](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/cf2be471-8c83-4033-a1de-d438d0a5ac48)
- [FDA Inspection 909929 - 2014-12-12](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/c47f05c2-002b-403f-a194-bf76d1a416b0)
- [FDA Inspection 772140 - 2012-02-14](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/e08e7dca-6507-42e4-81bf-4837d73135bc)

Company: https://www.keypedia.com/companies/evonik-operations-gmbh/e2b1ddde-f817-4199-afcc-3aeed833f429

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c